Niki BioSolutions, Inc. (NIKI) vs Skye Bioscience, Inc. (SKYE)
- Niki BioSolutions, Inc. NIKI 2.03 −8.56%
- Skye Bioscience, Inc. SKYE 1.55 −2.52%
Niki BioSolutions, Inc. and Skye Bioscience, Inc. are both Biotechnology companies. Niki BioSolutions, Inc. and Skye Bioscience, Inc. are of similar size ($7.0M and $6.9M). Skye Bioscience, Inc. has the higher net margin (0.00% vs −921.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Niki BioSolutions, Inc. leads on 7 and Skye Bioscience, Inc. on 4.
Valuation
Profitability
| Metric | NIKI | SKYE | Biotechnology median |
|---|---|---|---|
| Gross margin | (87.96%) | 68.04% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | (921.74%) | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 0.00% | (233.87%) | (56.36%) |
| Return on assets | 0.00% | (159.80%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack